Cardurion Pharmaceuticals Inc.

4 trials 1 recruiting Commercial sponsor

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

13 Countries active

2 Unique IMPs

100% Results reported

Phase II

100%

3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

CRD-4730 2 TOVINONTRINE 2

All trials

4 total

A Phase 2 Study of CRD-4730 in CPVT Recruiting

2024-515564-32-00 Phase II 4 countries CRD-4730
A Phase 2 Dose-Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejec… Ended

2023-508736-62-00 Phase II 12 countries TOVINONTRINE
A Phase 2 Clinical Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Preserved Ejecti… Ended

2023-508737-13-00 Phase II 9 countries TOVINONTRINE
A Phase 2 Study of CRD-4730 in CPVT Ended

2022-502845-83-00 Phase II 2 countries CRD-4730

Showing 1–4 of 4 trials

← All sponsors A–Z